BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 30854739)

  • 21. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
    Chen H; Tu SW; Hsieh JT
    J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
    Balasubramanian S; Adhikary G; Eckert RL
    Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasion.
    Estella C; Herrer I; Atkinson SP; Quiñonero A; Martínez S; Pellicer A; Simón C
    PLoS One; 2012; 7(1):e30508. PubMed ID: 22291969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.
    Chernov AV; Sounni NE; Remacle AG; Strongin AY
    J Biol Chem; 2009 May; 284(19):12727-34. PubMed ID: 19286653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.
    Wang P; Aronson WJ; Huang M; Zhang Y; Lee RP; Heber D; Henning SM
    Cancer Prev Res (Phila); 2010 Aug; 3(8):985-93. PubMed ID: 20628004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
    Farabegoli F; Govoni M; Spisni E; Papi A
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
    Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
    Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia.
    Park JW; Hong JS; Lee KS; Kim HY; Lee JJ; Lee SR
    J Nutr Biochem; 2010 Nov; 21(11):1038-44. PubMed ID: 19962294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms.
    Gupta K; Thakur VS; Bhaskaran N; Nawab A; Babcook MA; Jackson MW; Gupta S
    PLoS One; 2012; 7(12):e52572. PubMed ID: 23285096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
    Chinaranagari S; Sharma P; Chaudhary J
    Oncotarget; 2014 Aug; 5(16):7172-82. PubMed ID: 25115397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular targets for green tea in prostate cancer prevention.
    Adhami VM; Ahmad N; Mukhtar H
    J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
    Sen T; Dutta A; Chatterjee A
    Anticancer Drugs; 2010 Jul; 21(6):632-44. PubMed ID: 20527725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
    Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
    Nandakumar V; Vaid M; Katiyar SK
    Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
    Ho YC; Yang SF; Peng CY; Chou MY; Chang YC
    J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier.
    Maeda K; Kuzuya M; Cheng XW; Asai T; Kanda S; Tamaya-Mori N; Sasaki T; Shibata T; Iguchi A
    Atherosclerosis; 2003 Jan; 166(1):23-30. PubMed ID: 12482547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of matrix metalloproteinase secretion by green tea catechins in a three-dimensional co-culture model of macrophages and gingival fibroblasts.
    Morin MP; Grenier D
    Arch Oral Biol; 2017 Mar; 75():89-99. PubMed ID: 27825679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts.
    Yun JH; Pang EK; Kim CS; Yoo YJ; Cho KS; Chai JK; Kim CK; Choi SH
    J Periodontal Res; 2004 Oct; 39(5):300-7. PubMed ID: 15324350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer.
    Giudice A; Montella M; Boccellino M; Crispo A; D'Arena G; Bimonte S; Facchini G; Ciliberto G; Botti G; Quagliuolo L; Caraglia M; Capunzo M
    Curr Mol Med; 2017; 17(6):405-420. PubMed ID: 29256350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.